Back to dataset
National Bowel Cancer Audit 2017
You're previewing the first 4 rows of this file.
Download this fileData from National Bowel Cancer Audit - 2017 | |||||||
---|---|---|---|---|---|---|---|
Not set | Not set | Not set | Not set | Not set | Not set | Not set | Not set |
Source | Not set | Not set | Not set | Not set | Not set | Not set | Not set |
Table 7.1: | Case ascertainment and data completeness according to trust/hospital site | The Royal Marsden, Clatterbridge Centre for Oncology NHS Foundation Trust and The Christie Hospital NHS Foundation Trust are tertiary cancer centres that mainly provide oncological treatment for bowel cancer patients. The Royal Marsden and The Christie Hospital NHS Foundation Trust have been excluded from Case Ascertainment in this table. Clatterbridge Centre for Oncology NHS Foundation Trust has been excluded from all data in this table. | No cases submitted | ? Too few cases to report (<10) | Combined case ascertainment for Trust. Denominator 392 | * For the purposes of the Audit, the following recorded tumour stages are considered to be missing data: Tx, T9, Nx, N9, Mx,M9 | Not set |
Table 7.2: | Management of all patients reported to the audit according to trust/hospital site | The Royal Marsden, The Christie Hospital and The Clatterbridge Cancer Centre NHS Foundation Trusts are tertiary cancer centres that mainly provide oncological treatment for bowel cancer patients therefore have been excluded from Treatment Pathways, but included in Cancer Alliance totals. | No cases submitted | Not set | Not set | Not set | Not set |